Výsledky vyhledávání

Collaborative study for the establishment of Ph. Eur. Human immunoglobulin for electrophoresis BRP batch 4

Autor: M-E, Behr-Gross, E, Regourd, W, Holtkamp

Publikováno v: Pharmeuropa bioscientific notes. 2022

Due to the diminished stocks of the third batch of the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for Human immunoglobulin for electrophoresis, in 2020 the European Directorate for the Quality of MedicinesHealthCare (EDQ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9bdd61160126ff7eb815033ae5999c80
https://pubmed.ncbi.nlm.nih.gov/35791813

Zobrazit plný text záznamu

Collaborative study for the calibration of Ph. Eur. Heparin Low-Molecular-Mass for Assay Biological Reference Preparation batch 11

Autor: E, Terao, E, Regourd

Publikováno v: Pharmeuropa bioscientific notes. 2022

European Pharmacopoeia (Ph. Eur.) monograph 0828 prescribes two in vitro assays to evaluate the biological activity of low-molecular-mass heparin products. These assess the capacity of low-molecular-mass heparins to accelerate the inhibition of facto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1b64b707e32990df34785a29685b9598
https://pubmed.ncbi.nlm.nih.gov/35481431

Zobrazit plný text záznamu

Collaborative study for the establishment of Human immunoglobulin for anticomplementary activity BRP replacement batches 3, 4, 5 and 6

Autor: L, Miller, Z, Waibler, E, Regourd, S, Jouette

Publikováno v: Pharmeuropa bioscientific notes. 2022

Human immunoglobulin products are used for the treatment of a number of diseases, such as primary or secondary immunodeficiencies and autoimmune conditions due to the complete absence of antibodies or the production of defective immunoglobulins. Qual

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::429f945ec8e89bd23b1e6495e37c48c5
https://pubmed.ncbi.nlm.nih.gov/35384837

Zobrazit plný text záznamu

Establishment of a candidate equine influenza Florida Clade 2 strain A/eq/Richmond/1/07 horse antiserum as Ph. Eur. Biological Reference Preparation/OIE International Reference Reagent

Autor: R, Paillot, E, Regourd, M-E, Behr-Gross

Publikováno v: Pharmeuropa bio & scientific notes
Pharmeuropa bio & scientific notes, European Directorate for the Quality of Medicines & HealthCare, 2020, 2020, pp.125-140

International audience; Equine influenza (EI) is an important respiratory disease of horses, with welfare and economic consequences. Vaccination remains one of the most efficient prevention methods available. Equine influenza virus (EIV) is constantl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::23917652ef9a6ac182d57f490648cfb9
https://hal-normandie-univ.archives-ouvertes.fr/hal-02931045

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Collaborative study for the establishment of erythropoietin BRP batch 5

Autor: J, Ferguson, C J, Burns, E, Regourd, A, Costanzo

Publikováno v: Pharmeuropa bioscientific notes. 2019

The European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for erythropoietin (EPO) is used as a working standard for potency determination of EPO preparations by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::63a8349bea8f0ce5a69173ec520f2931
https://pubmed.ncbi.nlm.nih.gov/30880683

Zobrazit plný text záznamu

Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA

Autor: S, Morgeaux, A, Koy, I, Manniam, E, Regourd, P, Variot, C, Milne

Publikováno v: Pharmeuropa bioscientific notes. 2019

The European Pharmacopoeia (Ph. Eur.) standard ELISA method for determination of antigen content of hepatitis A vaccines (HAV) requires specific coating and detection Biological Reference Reagents (BRRs). The 4th batch of detection antibodies BRRs wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::681e9ea7a8dec10d8dcdf2f4bbe4ed1e
https://pubmed.ncbi.nlm.nih.gov/30648966

Zobrazit plný text záznamu

Collaborative study for the establishment of human immunoglobulin BRP replacement batches

Autor: D, Karra, E, Regourd, A, Costanzo

Publikováno v: Pharmeuropa bioscientific notes. 2018

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ac13cefa3a5f23541358dd968c7060f0
https://pubmed.ncbi.nlm.nih.gov/29944115

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání